Diosmin clinical trials
Also written Daflon.
How each study uses Diosmin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Diosmin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
23 studies that test it; most in 2023 (5)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 16
Ain Shams University (4) · Tanta University (4) · Pirogov Russian National Research Medical University (2) · Primus Pharmaceuticals (2) · Ittefaq Hospital trust (1) · Taipei Medical University Shuang Ho Hospital (1) · Laboratorios Andromaco S.A. (1) · Fundação Educacional Serra dos Órgãos (1)
Often tested with
Tested in the same studies.
Hesperidin (4) · Cabergoline (1) · Rebamipide (1) · Silymarin (1) · Flavonoids (1) · Loratadine (1) · Tranexamic Acid (1)
Related medicines
As reviewed, each with the page that says it.
- One of Antioxidants source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test Diosmin.
- Jul 2027Study of Diosmin for the Treatment of Digital Ulcers in Systemic SclerosisNot applicable · Primus Pharmaceuticals
- Aug 2027Clinical Study Comparing Diosmin vs Rebamipide as Adjuvant Therapies vs Conventional Therapy in Patients With Rheumatoid ArthritisPhase 2 · Tanta University
Studies
Open first, then newest update. How each study uses Diosmin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 23
- Study of Diosmin for the Treatment of Digital Ulcers in Systemic SclerosisRecruitingNot applicablePrimus PharmaceuticalsNCT06256575Written as Diosmin
- Clinical Study Comparing Diosmin vs Rebamipide as Adjuvant Therapies vs Conventional Therapy in Patients With Rheumatoid ArthritisRecruitingPhase 2Tanta UniversityNCT07745426Written as Diosmin
- Silymarin vs Hesperidin/Diosmin in FibromyalgiaRecruitingNot applicableAin Shams UniversityNCT07293767Written as Diosmin / Hesperidin (Daflon)
- Effect of Diosmin and Hesperidin in Treatment of Patients With Rheumatoid ArthritisRecruitingPhase 3Alexandria UniversityNCT05756179Written as Diosmin and Hesperidin Combination
- Evaluation of the Effects of Diosmin/Hespiridin Combination on the Clinical Outcomes in Patients With Polycystic Ovary SyndromeNot yet recruitingPhase 4Ain Shams UniversityNCT06083935Written as Daflon
- the Efficacy and Safety of Diosmin on Non-diabetic Patients With Non-alcoholic Steatohepatitis.RecruitingPhase 3Tanta UniversityNCT05942547Written as Diosmin
- Diosmin as Adjuvant Therapy in Treatment of Non-bleeding Peptic UlcerRecruitingPhase 3Tanta UniversityNCT05670457Written as Diosmin
- EFFECT OF DAFLON (DIOSMIN AND HESPERIDIN) ON POST-OPERATIVE SEROMA FORMATION IN BREAST CANCER SURGERY''CompletedPhase 4Ittefaq Hospital trustNCT07588828Written as Daflon (Diosmin and Hesperidin)
- Randomized Control Trial of Micronized Purified Flavonoid Fraction for Post Operative Treatment in Anal Fistula SurgeryCompletedPhase 4Taipei Medical University Shuang Ho HospitalNCT06184438Written as Micronized purified flavonoid fraction(Daflon 1000mg)
- Clinical Study to Evaluate the Possible Efficacy and Safety of Diosmin and Hesperidin Combined Therapy in Patients With Helicobacter Pylori InfectionStatus unknownPhase 1/2Sadat City UniversityNCT06546111Written as Daflon
- Safety and Efficacy of Vasculera® in the Healing of Diabetic Skin UlcersWithdrawnNot applicablePrimus PharmaceuticalsNCT02361437Written as Vasculera
- the Efficacy and Safety of Diosmin in Patients With Ulcerative ColitisStatus unknownPhase 3Tanta UniversityNCT05626166Written as Diosmin
- Randomised, Double-blind, Placebo-controlled to Assess the Efficacy and Safety of the Food Supplement Microsmin® PlusStatus unknownNot applicableGiellepi S.p.ANCT05750563Written as diosmin and micronized flavonoids
- Impact of Treatment With VENARUS® on the Level of Monocyte Chemoattractant Protein 1 in Varicose Veins BloodCompletedNot applicablePirogov Russian National Research Medical UniversityNCT04933591Written as Diosmin / Hesperidin
- Evaluation of The Effect of Loratadine Versus Diosmin/Hesperidin Combination on Vinca Alkaloids Induced NeuropathyStatus unknownPhase 3Ain Shams UniversityNCT05243706Written as Diosmin/ Hesperidin
- Bioavailability of Diosmin/Hesperidin (90/10) 500 mg Tablets With Regards to Reference ProductCompletedPhase 1Laboratorios Andromaco S.A.NCT05158192Written as Diosmin/Hesperidin (90/10) 500 mg Test Drug
- Rivaroxaban With Diosmin in Long-term Treatment of Deep Vein ThrombosisCompletedPhase 4Pirogov Russian National Research Medical UniversityNCT03413618Written as Diosmin
- Clinical Non-inferiority Study Between Diosmin 600mg & Diosmin + Hesperidin in Symptomatic Chronic Venous InsufficiencyCompletedPhase 4Fundação Educacional Serra dos ÓrgãosNCT03471910Written as Diosmin
- Diosmin Versus Cabergoline for Prevention of Ovarian Hyperstimulation SyndromeCompletedPhase 2/3Benha UniversityNCT02134249Written as Diosmin
- Oral Tranexamic Acid Versus Diosmin for Treatment of Menorrhagia in Women Using Copper IUDStatus unknownPhase 1/2Ain Shams UniversityNCT02616731Written as Diosmin
See all 23 studies that test Diosmin →
Given beside what is tested · 1 — Diosmin is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with Diosmin
- Glue Embolization vs Conservative Treatment for Pelvic Congestion SyndromeRecruitingNot applicableTanta UniversityNCT06560294Written as Micronized purified flavonoid fraction (Daflon ®)
- Comparative Efficacy of Two Preparations of the Association Diosmin (450 mg) + Hesperidin (50 mg) in the Treatment of Chronic Venous Insufficiency (CVI)Status unknownPhase 3Azidus BrasilNCT01110512Written as Daflon
Codes
What other systems call Diosmin · ClinicalTrials.gg INT007375
- MeSH (NLM) D004145DiosminConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 7QM776WJ5NDIOSMINConfirmed FDA, NLM, Wikidata
- RxNorm 3489Confirmed FDA, Wikidata
- Wikidata Q2607865diosminConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C81663DiosminOne source FDA
- DrugBank DB08995One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D004145 | Diosmin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 7QM776WJ5N | DIOSMIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 3489 | — | Confirmed FDA, Wikidata |
| Wikidata | Q2607865 | diosmin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C81663 | Diosmin | One source FDA |
| DrugBank | DB08995 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.